Reply to the letter from Robertson to Blamey
Breast Cancer and Bone Recurrence
publication
Author Information
Author(s): RE Coleman, RD Rubens
Primary Institution: The University of Sheffield, Weston Park Hospital NHS Trust
Hypothesis
What factors predict the clinical course of breast cancer patients with bone as the first site of recurrence?
Conclusion
The study aims to identify patient groups likely to experience skeleton-related events and benefit from bisphosphonate treatment.
Supporting Evidence
- The study contains 4-5 times the number of patients with bone recurrence compared to previous references.
- The aim is to define groups of patients who will benefit most from bisphosphonate treatment.
Takeaway
This study looks at breast cancer patients whose cancer comes back in their bones to find out who might need special treatment.
Methodology
The study used Cox regression analysis to evaluate prognostic factors.
Participant Demographics
Patients with advanced breast cancer and bone as the first site of recurrence.
Want to read the original?
Access the complete publication on the publisher's website